Emergent BioSolutions Inc.EBSNYSE
Loading
Enterprise value to EBITDA ratio
3Y CAGR
-61.7%/yr
vs +38.9%/yr prior
5Y CAGR
-9.8%/yr
Recent deceleration
Acceleration
-100.6pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.93 | -75.7% |
| 2024 | 20.29 | +209.4% |
| 2023 | -18.54 | -121.2% |
| 2022 | 87.61 | +1585.8% |
| 2021 | 5.20 | -37.0% |
| 2020 | 8.25 | -38.1% |
| 2019 | 13.32 | -43.5% |
| 2018 | 23.55 | +131.3% |
| 2017 | 10.18 | +2.8% |
| 2016 | 9.90 | - |